Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy — a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection — but growth hormone treatment also appeared to increase blood glucose levels, particularly in those already exhibiting glucose intolerance.